TactiCath Quartz CFA Catheter
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $14,692 | 338 | 182 |
| 2020 | $88,479 | 347 | 184 |
| 2019 | $188,911 | 804 | 423 |
| 2018 | $281,108 | 647 | 327 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $233,261 | 179 | 40.7% |
| Unspecified | $195,528 | 54 | 34.1% |
| Food and Beverage | $79,367 | 1,664 | 13.8% |
| Travel and Lodging | $43,755 | 214 | 7.6% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $18,313 | 19 | 3.2% |
| Compensation for serving as faculty or as a speaker for a medical education program | $2,500 | 1 | 0.4% |
| Education | $466.97 | 5 | 0.1% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Multi-Center Acute Safety Trial of TactiCath Contact Force Ablation Catheter Sensor Enabled (TactiCath SE) for the Treatment of Drug Refractory Recurrent Symptomatic Paroxysmal Atrial Fibrillation | Abbott Laboratories | $195,528 | 0 |
Top Doctors Receiving Payments for TactiCath Quartz CFA Catheter
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Olympia, WA | $195,528 | 54 |
| , M.D | Cardiovascular Disease | Saint Paul, MN | $40,734 | 13 |
| , MD PHD | Internal Medicine | Boston, MA | $28,222 | 44 |
| , M.D., M.H.S | Cardiovascular Disease | Lumberton, NC | $26,964 | 31 |
| , M.D | Clinical Cardiac Electrophysiology | Plainsboro, NJ | $19,193 | 28 |
| , MD | Cardiovascular Disease | Salt Lake City, UT | $17,998 | 26 |
| , M.D | Cardiovascular Disease | Mt Pleasant, SC | $14,260 | 26 |
| , M.D | Cardiovascular Disease | New York, NY | $13,691 | 30 |
| , MD | Cardiovascular Disease | New York, NY | $11,961 | 20 |
| , MD | Clinical Cardiac Electrophysiology | Lincoln, NE | $11,860 | 10 |
| , M.D | Cardiovascular Disease | Austin, TX | $10,379 | 23 |
| , MD | Clinical Cardiac Electrophysiology | Little Rock, AR | $9,083 | 17 |
| , M.D | Cardiovascular Disease | Saint Paul, MN | $8,622 | 26 |
| , M.D | Clinical Cardiac Electrophysiology | Los Angeles, CA | $7,575 | 18 |
| , M.D | Clinical Cardiac Electrophysiology | New York, NY | $7,160 | 3 |
| , MD | Clinical Cardiac Electrophysiology | Boise, ID | $6,351 | 11 |
| , M.D | Cardiovascular Disease | Minneapolis, MN | $5,637 | 14 |
| , MD | Cardiovascular Disease | Boise, ID | $5,471 | 9 |
| , MD | Clinical Cardiac Electrophysiology | Salt Lake City, UT | $4,955 | 10 |
| , MD | Clinical Cardiac Electrophysiology | Philadelphia, PA | $4,929 | 6 |
| , M.D | Cardiovascular Disease | Eatontown, NJ | $4,505 | 8 |
| , MD | Internal Medicine | Memphis, TN | $4,050 | 3 |
| , MBBS | Cardiovascular Disease | Minneapolis, MN | $2,759 | 3 |
| , MD | Cardiovascular Disease | Radnor, PA | $2,755 | 6 |
| , MD | Clinical Cardiac Electrophysiology | Fort Lauderdale, FL | $2,740 | 17 |
Manufacturing Companies
- Abbott Laboratories $573,191
Product Information
- Type Device
- Total Payments $573,191
- Total Doctors 856
- Transactions 2,136
About TactiCath Quartz CFA Catheter
TactiCath Quartz CFA Catheter is a device associated with $573,191 in payments to 856 healthcare providers, recorded across 2,136 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.
Payment data is available from 2018 to 2021. In 2021, $14,692 was paid across 338 transactions to 182 doctors.
The most common payment nature for TactiCath Quartz CFA Catheter is "Consulting Fee" ($233,261, 40.7% of total).
TactiCath Quartz CFA Catheter is associated with 1 research study, including "Multi-Center Acute Safety Trial of TactiCath Contact Force Ablation Catheter Sensor Enabled (TactiCath SE) for the Treatment of Drug Refractory Recurrent Symptomatic Paroxysmal Atrial Fibrillation" ($195,528).